VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IRIXIRIDEX Corporation
$1.14$20M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIRIXBalance Sheet

IRIDEX Corporation (IRIX) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial position appears increasingly strained as the debt-to-equity ratio surged to 0.90 in 2026Q1 from 0.29 in 2023Q4, while total equity eroded to $4.7M.

IRIX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets24.58M25.25M23.56M27.45M35.77M42.25M25.36M30.55M39.62M39.45M45.87M30.77M32.89M31.97M27.05M29.51M26.37M26.33M25.69M35.5M37.87M38.92M32.65M33.47M31.05M30.33M31.53M29M25.9M24.5M17.8M
Cash & Short-Term Investments4.59M6.03M2.39M7.03M13.92M23.85M11.63M12.65M21.19M21.71M23.75M9.99M13.3M13.44M11.9M10.79M9.01M9.38M5.31M5.81M21.05M21.43M13.7M16.29M11.54M9.1M12.99M13.15M5.8M9.9M5M
Cash Only4.59M6.03M2.39M7.03M13.92M23.85M11.63M12.65M21.19M21.71M23.75M9.99M13.3M13.44M11.9M10.79M9.01M9.38M5.31M5.81M21.05M12.65M10.38M10.54M9.19M4.61M10M9.64M5.8M9.9M5M
Short-Term Investments0000000000000000000008.78M3.32M5.75M2.36M4.49M3M3.5M000
Accounts Receivable8.42M9.54M8.39M9.65M9.77M9.72M7.29M9.32M9.08M7.86M10.03M9.28M8.34M7.34M5.48M5.55M7.53M7.48M8.2M8.88M6.05M6.59M7.4M6.55M8.04M8.07M8.01M8.16M7.6M6.1M5.4M
Days Sales Outstanding65.1266.1462.9567.9362.5865.7973.278.3277.826979.2781.1371.0870.0559.0761.162.8763.261.6758.3461.5264.9582.3775.495.76107.9487.44111.32117.54123.01158.95
Inventory9.32M7.88M10.82M9.91M10.61M7.61M5.71M8.17M8.79M9.38M11.64M11.11M9.12M10.61M8.04M6.66M9.21M9M11.64M15.97M9.5M8.59M8.92M8.72M10.72M12.56M9.72M7.26M6.5M4M1.9M
Days Inventory Outstanding89.4986.16135.37120.27122.5189.44100.32116.96127.73131.24167.85185.91155.47196.63167.46144.08147.53143.19147.32186.51202.77166.37181.71180.57229.65322.78258.14241.4247.14202.78147.55
Other Current Assets2.25M1.8M1.96M856K1.47M000547K500K450K386K1.63M0510K6.04M6.55M003.8M01.42M1.81M972K00805K437K6M4.5M5.5M
Total Non-Current Assets3.69M3.9M5.57M6.99M6.52M6.43M2.61M4.26M2.05M2.19M2.28M11.05M8.92M1.71M1.86M2.64M2.85M1.96M2.54M11.15M2.31M2.19M6.44M2.37M3.22M3.46M3.5M3.66M2.5M2.2M5.9M
Property, Plant & Equipment635K826K1.91M2.98M2.13M2.99M1.88M3.49M1.22M1.4M1.53M1.1M735K543K483K325K360K486K832K1.62M1.09M1.11M852K850K950K1.53M1.9M2.14M2.3M2.1M700K
Fixed Asset Turnover54.51x63.77x25.52x17.39x26.79x18.01x19.36x12.43x34.92x29.65x30.09x37.82x58.25x70.48x70.10x102.03x121.37x88.91x58.33x34.26x33.03x33.24x38.51x37.29x32.25x17.77x17.57x12.48x10.26x8.62x17.71x
Goodwill965K965K965K965K965K965K533K533K533K533K533K533K533K533K533K533K473K003.24M00000000000
Intangible Assets904K984K1.31M1.64M1.98M2.21M68K84K100K116K132K268K284K328K554K745K1.8M1.15M1.47M5.94M00000000100K00
Long-Term Investments0000000000000-9.97M-10.06M00000004.32M001K4K-3K000
Other Non-Current Assets1.19M1.12M1.39M1.4M1.46M271K132K151K201K143K80K164K221K303K287K1.04M218K323K229K347K1.22M04.32M001.92M1.59M1.52M100K100K5.2M
Total Assets28.27M29.15M29.14M34.44M42.29M48.69M27.97M34.81M41.67M41.65M48.14M41.82M41.82M33.68M28.91M32.15M29.22M28.29M28.23M46.65M40.18M41.1M39.09M35.84M34.27M33.79M35.02M32.66M28.4M26.7M23.7M
Asset Turnover1.79x1.81x1.67x1.51x1.35x1.11x1.30x1.25x1.02x1.00x0.96x1.00x1.02x1.14x1.17x1.03x1.50x1.53x1.72x1.19x0.89x0.90x0.84x0.88x0.89x0.81x0.95x0.82x0.83x0.68x0.52x
Asset Growth %-22.26%0.05%-15.39%-18.57%-13.14%74.07%-19.66%-16.46%0.06%-13.5%15.11%0.01%24.17%16.48%-10.07%10.02%3.28%0.23%-39.5%16.12%-2.26%5.14%9.08%4.57%1.43%-3.53%7.22%15.02%6.37%12.66%270.31%
Total Current Liabilities12.83M13.21M16.56M12.97M12.45M12.65M8.68M9.78M11.09M10.39M8.46M7.43M7.04M7.36M6.37M8.91M9.2M13.12M16.48M27.84M8.02M6.59M7.31M5M4.07M3.96M4.53M5.16M2.5M2.8M2.2M
Accounts Payable5.75M5.5M6.99M4.5M3.86M2.77M1.15M2.59M2.52M1.72M1.99M2.22M1.76M2.28M2.1M1.58M1.51M1.87M2.42M2.89M1.83M1.09M1.23M1.03M657K1.18M1.41M1.13M879K800K500K
Days Payables Outstanding57.5760.1887.4154.6244.5632.5620.1637.0936.5524.1228.7537.2129.9742.2443.8734.1924.2529.7930.5533.7239.0621.1825.1121.3114.0730.2237.3937.5333.4240.5638.83
Short-Term Debt424K699K1.73M0001.25M00000000003.52M6M9.88M00000000000
Deferred Revenue (Current)8.68M2.16M3.49M3.33M3.38M3.45M938K2.23M2.23M2.52M1.38M1.31M1.18M1.13M1M1.13M2.13M2.4M2.74M3.35M1.42M1.07M910K596K0000000
Other Current Liabilities2.89M4.85M770K1.62M2.45M3.19M1.97M2.78M3.23M3.63M2.64M2.22M2.13M2.06M1.7M4.4M4.64M000000-3.38M003.12M4.03M1.62M2M1.7M
Current Ratio1.92x1.91x1.42x2.12x2.87x3.34x2.92x3.12x3.57x3.80x5.42x4.14x4.67x4.34x4.25x3.31x2.87x2.01x1.56x1.28x4.72x5.91x4.47x6.69x7.62x7.67x6.97x5.62x10.36x8.75x8.09x
Quick Ratio1.19x1.32x0.77x1.35x2.02x2.74x2.26x2.29x2.78x2.89x4.04x2.65x3.38x2.90x2.99x2.56x1.87x1.32x0.85x0.70x3.54x4.60x3.25x4.94x4.99x4.49x4.82x4.21x7.76x7.32x7.23x
Cash Conversion Cycle97.0392.12110.91133.58140.54122.67153.36158.2169.01176.12218.37229.84196.57224.44182.67171186.15176.6178.43211.12225.23210.14238.96234.67311.34400.51308.19315.2331.26285.23267.68
Total Non-Current Liabilities10.71M11.02M10.48M11.94M12.61M12.74M1.92M2.33M623K732K523K704K1.04M461K640K810K596K149K00005.17M3.38M0000000
Long-Term Debt3.77M3.73M1M0001.25M000000000000000000000000
Capital Lease Obligations485K98K811K1.75M732K1.73M282K1.79M00000000000000000000000
Deferred Tax Liabilities0000000000007.15M000000000000000000
Other Non-Current Liabilities440K387K314K164K132K83K103K175K623K732K523K704K1.04M461K640K810K596K00000000000000
Total Liabilities23.54M24.23M27.04M24.91M25.06M25.39M10.6M12.11M11.71M11.12M8.98M8.13M8.08M7.82M7.01M9.72M9.79M13.27M16.48M27.84M8.02M6.59M7.31M5M4.07M3.96M4.53M5.16M2.5M2.8M2.2M
Total Debt4.28M4.53M4.64M2.75M1.77M2.66M4.19M3.21M0000000003.52M6M9.88M000000000010K
Net Debt-319K-1.5M2.26M-4.29M-12.15M-21.2M-7.44M-9.44M-21.19M-21.71M-23.75M-9.99M-13.3M-13.44M-11.9M-10.79M-9.01M-5.86M693K4.07M-21.05M-12.65M-10.38M-10.54M-9.19M-4.61M-10M-9.64M-5.8M-9.9M-4.99M
Debt / Equity0.90x0.92x2.21x0.29x0.10x0.11x0.24x0.14x---------0.23x0.51x0.53x----------0.00x
Debt / EBITDA-2.81x----------------1.03x------------0.01x
Net Debt / EBITDA0.21x-----------12.34x-4.42x-4.30x--4.60x-2.72x-1.71x----5.64x--16.09x-13.35x--2.72x-3.65x-2.32x-3.19x-4.16x
Interest Coverage------------1.06x7.10x-1.29x9.24x46.12x14.00x-13.29x-33.56x-----------
Total Equity4.73M4.92M2.1M9.52M17.23M23.3M17.37M22.7M29.96M30.52M39.16M33.69M33.74M25.85M21.91M22.43M19.43M15.03M11.75M18.81M32.16M34.52M31.78M30.83M30.2M29.83M30.5M27.5M25.9M23.9M21.5M
Equity Growth %711.27%134.72%-77.98%-44.74%-26.04%34.16%-23.51%-24.22%-1.84%-22.06%16.24%-0.14%30.49%18.03%-2.32%15.44%29.29%27.92%-37.55%-41.51%-6.84%8.6%3.08%2.11%1.22%-2.19%10.89%6.19%8.37%11.16%357.45%
Book Value per Share0.270.290.130.591.081.511.251.662.462.643.853.333.262.562.452.191.921.681.332.274.174.384.414.164.364.424.194.023.833.543.44
Total Shareholders' Equity4.73M4.92M2.1M9.52M17.23M23.3M17.37M22.7M29.96M30.52M39.16M33.69M33.74M25.85M21.91M22.43M19.43M15.03M11.75M18.81M32.16M34.52M31.78M30.83M30.2M29.83M30.5M27.5M25.9M23.9M21.5M
Common Stock174K174K174K172K169K168K148K147K145K126K124K111K108K104K94K92K89K89K89K89K79K76K74K70K70K69K67K66K70K00
Retained Earnings-92.97M-92.45M-88.01M-79.04M-69.72M-62.17M-56.94M-50.62M-41.8M-28.99M-16.12M-4.41M-4.88M-14.92M-17.15M-18.59M-21.2M-24.25M-26.83M-19.46M2.81M8.56M6.89M7.29M6.92M6.77M7.73M5.32M4M2.3M200K
Treasury Stock000000000000000-1.08M-430K-430K-430K-430K-430K-430K-430K-430K-430K-430K00000
Accumulated OCI-10K-14K51K-52K-24K45K-19K80K70K-11.05M-10.34M-9.7M000-35K-205K-212K-192K-88K0-27K-35K-1K3K3K10K-2K20K-900K-700K
Minority Interest0000000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and capital constraints

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Eroding Equity Base Signals Distress

As reported in financial statements, IRIDEX's total equity has contracted from $9.5M in 2023Q4 to $4.7M in 2026Q1, reflecting a persistent erosion of shareholder value driven by cumulative net losses that continue to weigh heavily on the company's overall financial position and long-term stability.

The consistent decline in equity highlights the company's inability to generate retained earnings, effectively forcing a reliance on external financing or asset liquidation to fund operations. This trajectory suggests that the business model has yet to reach a critical mass where operational scale can offset the ongoing depletion of capital.

Tight Cash Runway Limits Flexibility

Based on recent SEC filings, IRIDEX maintains a cash position of $4.6M as of 2026Q1, which represents a significant reduction from the $7.0M held in 2023Q4, indicating a narrowing buffer against operational shocks and potential volatility in working capital requirements for the medical device manufacturer.

While the current ratio of 1.92 suggests a superficial level of liquidity, the absolute cash balance remains low relative to the company's historical burn rate. Investors should monitor whether this liquidity level is sufficient to sustain R&D and sales efforts without necessitating dilutive capital raises in the near term.

Leverage Ratios Reflect Financial Strain

According to reported figures, IRIDEX's debt-to-equity ratio has surged to 0.90 in 2026Q1 from 0.29 in 2023Q4, demonstrating that the company is increasingly reliant on debt financing to bridge the gap between its operational cash outflows and its capital requirements in a challenging market environment.

The rising leverage profile, coupled with persistent operating losses, suggests that the company's debt capacity may be reaching a ceiling. This shift warrants further investigation into the terms of existing credit facilities and the potential for refinancing risks if the company fails to improve its cash flow generation.

Deferred Revenue Trends Indicate Deceleration

As indicated by the company's balance sheet data, deferred revenue has declined from $13.4M in 2023Q4 to $8.5M in 2026Q1, which may suggest a softening in the pipeline of future service obligations and a potential headwind for near-term revenue recognition and growth prospects.

The contraction in deferred revenue is a concerning indicator for a company that relies on a recurring revenue model through service contracts and consumable pull-through. This trend implies that the underlying demand for the company's installed base may be weakening, potentially impacting future cash inflows.

IRIX — Frequently Asked Questions

Quick answers to the most common questions about buying IRIX stock.

What are the total assets of IRIDEX Corporation (IRIX)?

As of 2025, IRIDEX Corporation (IRIX) had total assets of $29.2M including $25.3M in current assets.

How much debt does IRIDEX Corporation (IRIX) have?

IRIDEX Corporation (IRIX) carries total debt of $4.5M, offset by $6.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of IRIDEX Corporation?

IRIDEX Corporation (IRIX) has total shareholders' equity (book value) of $4.9M ($0.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is IRIDEX Corporation's current ratio and liquidity?

IRIDEX Corporation (IRIX) reported a current ratio of 1.91x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.